AFT Pharmaceuticals ROA 2024

AFT Pharmaceuticals Aktienanalyse

Šta radi AFT Pharmaceuticals?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA у детаљу

Razumevanje rentabilnosti kapitala (ROA) od AFT Pharmaceuticals

Rentabilnost kapitala (ROA) od AFT Pharmaceuticals je ključni pokazatelj koji meri profitabilnost preduzeća u odnosu na ukupnu imovinu. Izračunava se deljenjem neto dobitka sa ukupnom imovinom. Viša ROA ukazuje na efikasniju upotrebu imovine za stvaranje profita i odražava efikasnost upravljanja i finansijsko zdravlje.

Poređenje godina za godinom

Upoređivanje ROA od AFT Pharmaceuticals iz godine u godinu pruža uvid u operativnu efikasnost i trendove u korišćenju imovine preduzeća. Rastuća ROA ukazuje na poboljšanu efikasnost imovine i profitabilnost, dok smanjenje ROA može ukazivati na operativne ili finansijske izazove.

Utjecaj na investicije

Investitori smatraju ROA od AFT Pharmaceuticals ključnom metrikom za ocenu profitabilnosti i efikasnosti preduzeća. Veća ROA znači da preduzeće efikasno koristi svoju imovinu za stvaranje profita, što ga čini potencijalno privlačnom investicijom.

Tumačenje fluktuacija ROA

Fluktuacije u ROA od AFT Pharmaceuticals mogu biti posledica promena u neto dobiti, sticanju imovine ili operativnoj efikasnosti. Analiza ovih fluktuacija pomaže u ocenjivanju finansijskog učinka, efikasnosti upravljanja i strateškog pozicioniranja finansija preduzeća.

Često postavljana pitanja o AFT Pharmaceuticals akciji

Koliki je povrat na imovinu (ROA) kompanije AFT Pharmaceuticals ove godine?

Rentabilnost imovine (ROA) kompanije AFT Pharmaceuticals iznosi ove godine 0 undefined.

Koliki je bio ROA kompanije AFT Pharmaceuticals u poređenju sa prethodnom godinom?

ROA kompanije AFT Pharmaceuticals se u poređenju sa prošlom godinom promenio za -100,00% .

Koje posledice visok ROA ima za investitore od AFT Pharmaceuticals?

Visok ROA je povoljan za investitore AFT Pharmaceuticals jer ukazuje na to da kompanija efikasno koristi svoju imovinu i ostvaruje dobre dobitke.

Koje posledice imaju niski ROA za investitore od AFT Pharmaceuticals?

Nizak ROA može biti nepovoljan za investitore AFT Pharmaceuticals jer ukazuje na to da kompanija neefikasno koristi svoju imovinu i možda ostvaruje manje dobiti.

Kako povećanje ROA od AFT Pharmaceuticals utiče na preduzeće?

Povećanje ROA za AFT Pharmaceuticals može biti indikator poboljšane efikasnosti u korišćenju imovine i veće profitabilnosti.

Kako smanjenje ROA od AFT Pharmaceuticals utiče na kompaniju?

Smanjenje ROA od AFT Pharmaceuticals može biti indikator lošije efikasnosti u korišćenju imovine i niže profitabilnosti.

Koji su neki faktori koji mogu uticati na ROA od AFT Pharmaceuticals?

Neki faktori koji mogu uticati na ROA kompanije AFT Pharmaceuticals uključuju, između ostalog, promet, operativne troškove, strukturu imovine i prosečne vrednosti u industriji.

Zašto je ROA kompanije AFT Pharmaceuticals važna za investitore?

ROA kompanije AFT Pharmaceuticals je važan za investitore jer je indikator profitabilnosti preduzeća i njegove efikasnosti u upotrebi imovine. Pruža investitorima informacije o tome koliko dobro kompanija koristi svoja sredstva za ostvarivanje profita.

Koje strateške mere može AFT Pharmaceuticals preduzeti kako bi poboljšao ROA?

Da bi poboljšali ROA, AFT Pharmaceuticals može između ostalog preduzeti mere kao što su smanjenje troškova, povećanje prihoda, optimizacija strukture imovine i diverzifikacija poslovanja. Važno je da kompanija sprovede temeljitu proveru svoje finansijske situacije kako bi odredila najbolje strateške mere za poboljšanje ROA.

Kolika je dividenda koju isplaćuje AFT Pharmaceuticals?

U poslednjih 12 meseci, AFT Pharmaceuticals je isplatio dividendu u iznosu od 0,02 NZD . To odgovara dividendnom prinosu od oko 0,50 %. Za narednih 12 meseci, AFT Pharmaceuticals će verovatno isplatiti dividendu od 0,02 NZD.

Kolika je dividendna prinosa za AFT Pharmaceuticals?

Dividendski prinos od AFT Pharmaceuticals trenutno iznosi 0,50 %.

Kada AFT Pharmaceuticals isplaćuje dividendu?

AFT Pharmaceuticals isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od AFT Pharmaceuticals?

AFT Pharmaceuticals je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije AFT Pharmaceuticals?

Za narednih 12 meseci očekuju se dividende u iznosu od 0,02 NZD. To odgovara dividendnom prinosu od 0,50 %.

U kom sektoru se nalazi AFT Pharmaceuticals?

AFT Pharmaceuticals se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od AFT Pharmaceuticals od 4. 7. 2024. u iznosu od 0,016 NZD, morali ste da imate akciju u depou pre Ex-dana 19. 6. 2024..

Kada je AFT Pharmaceuticals poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 4. 7. 2024..

Kolika je bila dividenda od AFT Pharmaceuticals u godini 2023?

U godini 2023 kompanija AFT Pharmaceuticals je isplatila 0,011 NZD kao dividende.

U kojoj valuti AFT Pharmaceuticals isplaćuje dividendu?

Dividende od AFT Pharmaceuticals se isplaćuju u NZD.